StockData
Janux Therapeutics, Inc. logo

Janux Therapeutics, Inc. (JANX) shareholders

JANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3035% below fair value
$10.71−0.21 (-1.92%)

Close on Nov 17, 2026Market cap $654.78MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
62M of 61M shares
Institutional holders
198
41 new, 30 sold out
Net institutional buying
6M
In Q2 2026
Insider trades, 12 months
0 buys · 10 sales
Net sold $457.06K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Peter Kolchinsky
Joint filing with RA Capital Management, L.P. (19.90%), Rajeev Shah (19.90%) and 1 more
11,971,37719.90%13D (active) amendmentMar 6, 2025
Janus Henderson Group PLC4,196,4096.90%13G (passive) amendmentMar 31, 2026
BlackRock, Inc.4,098,4576.70%13G (passive) amendmentJun 30, 2026
W. Lawrence Hawkins
Joint filing with Prosight Management, LP (5.20%), Prosight Partners, LLC (5.20%)
3,157,2205.30%13G (passive)Feb 3, 2026
Steven A. Cohen
Joint filing with Point72 Asset Management, L.P. (5.00%), Point72 Capital Advisors, Inc. (5.00%)
3,069,7595.00%13G (passive)Apr 28, 2026
Adage Capital Management, L.P.
Joint filing with Robert Atchinson (5.31%), Phillip Gross (5.31%)
3,061,7505.31%13G (passive)Dec 31, 2024
Bregua Corporation2,999,9905.80%13G (passive) amendmentSep 30, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of JANXValueChange% of portfolio
Ra Capital Management, L.P.11,189,69318.30%$171.87M–1.49%
BlackRock, Inc.6,134,66710.03%$94.23M+701,4340.00%
Prosight Management, LP3,804,4816.22%$58.44M+254,48110.07%
State Street Corp3,004,8994.92%$46.16M+540,8820.00%
FMR LLC2,412,8253.95%$37.06M−122,8990.00%
Federated Hermes, Inc.2,352,9273.85%$36.14M+2,298,7270.05%
Point72 Asset Management, L.P.1,993,8373.26%$30.63M+837,6970.03%
Vanguard Capital Management LLC1,857,3513.04%$28.53M+45,9860.00%
TCG Crossover Management, LLC1,789,6172.93%$27.49M–0.66%
Alyeska Investment Group, L.P.1,647,1402.69%$25.30M+46,0510.07%
Nantahala Capital Management, LLC1,619,8282.65%$24.88M+809,9140.41%
Wellington Management Group Llp1,507,3602.47%$23.15M−90,2900.00%
Vanguard Portfolio Management LLC1,330,7102.18%$20.44M+40,4540.00%
Two Sigma Investments, LP1,207,2501.97%$18.54M+1,091,1510.01%
Geode Capital Management, LLC1,204,1501.97%$18.50M+57,4260.00%
Citadel Advisors LLC1,200,7371.96%$18.44M+848,5600.00%
Algert Global LLC1,110,8891.82%$17.06M+667,4920.20%
D. E. Shaw & Co., Inc.1,096,5091.79%$16.84M+998,1140.01%
Goldman Sachs Group Inc952,6751.56%$14.63M+350,6620.00%
Bank Of America Corp /De/910,4601.49%$13.98M+108,8140.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202619862M100.0%41 / 8445 / 3013M7M
Q1 202619060M97.5%46 / 6654 / 2913M13M
Q4 202517662M100.0%44 / 6941 / 3816M19M
Q3 202517465M100.0%22 / 5863 / 227M7M
Q2 202517466M100.0%16 / 8054 / 228M8M
Q1 202518267M100.0%19 / 9644 / 529M7M
Q4 202421664M100.0%78 / 8043 / 2121M2M
Q3 202416046M74.7%33 / 5351 / 278M7M
Q2 202415546M75.6%55 / 5833 / 1911M8M
Q1 202412143M70.6%63 / 2528 / 613M3M
Q4 20236434M55.0%14 / 2711 / 71M3M
Q3 20235735M57.4%9 / 2316 / 65M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

186 funds held JANX in Q2 2026, 51% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of JANXValue% of fundAs of
State Street(R) SPDR(R) S&P(R) Biotech ETF1,928,4913.15%$29.62M0.28%Jun 30, 2026
Federated Hermes MDT Small Cap Core Fund1,374,1152.25%$20.85M0.93%Jul 31, 2026
Vanguard Total Stock Market Index Fund1,263,8372.07%$19.41M0.00%Jun 30, 2026
iShares Russell 2000 ETF1,127,7761.84%$17.32M0.02%Jun 30, 2026
Vanguard Extended Market Index Fund552,3680.90%$8.48M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund471,4600.77%$7.15M0.02%Jul 31, 2026
Vanguard Strategic Equity Fund423,6460.69%$6.51M0.05%Jun 30, 2026
iShares Russell 2000 Value ETF405,4170.66%$6.23M0.04%Jun 30, 2026
iShares Biotechnology ETF403,6720.66%$6.20M0.07%Jun 30, 2026
Nuveen Quant Small Cap Equity Fund381,0000.62%$5.78M0.14%Jul 31, 2026
BlackRock Advantage Small Cap Core Fund380,6200.62%$5.55M0.11%May 29, 2026
Federated Hermes MDT Small Cap Growth Fund376,4250.62%$5.71M0.68%Jul 31, 2026
Bridge Builder Small/Mid Cap Growth Fund340,7410.56%$5.23M0.05%Jun 30, 2026
Fidelity Series Small Cap Core Fund328,5000.54%$4.98M0.32%Jul 31, 2026
Vanguard Explorer Fund326,3620.53%$4.95M0.02%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
David Alan CampbellPresident and CEO, Director264,7420.43%Jul 31, 2026
Janeen Noel DoyleChief Corp. & Bus. Dev. Ofcr75,9410.12%Jun 4, 2026
Maria DobekVice President, Accounting32,2700.05%May 13, 2026
William GoChief Medical Officer44,0000.07%Feb 4, 2026
Andrew Hollman MeyerChief Business Officer83,0950.14%Jan 2, 2026
Charles M. WinterChief Technical Officer77,7210.13%Jan 2, 2026
Thomas DiRaimondoChief Scientific Officer155,8250.25%Jan 2, 2026
Zachariah McIverChief Medical Officer23,2860.04%Jan 2, 2026
Byron RobinsonChief Strategy Officer28,0000.05%Jan 3, 2025
Vickie L. CappsDirector79,5980.13%Jun 12, 2026
Jake SimsonDirector11,7500.02%Jun 12, 2026
Capital Healthcare Fund LP RADirector, 10% owner6,2500.01%Jun 12, 2026
Ronald W. BarrettDirector11,7500.02%Jun 12, 2026
Eric DobmeierDirector15,4810.03%Jun 12, 2026
RA Capital Nexus Fund II, L.P.Director11,7500.02%Jun 12, 2026
Winston KungDirector11,7500.02%Jun 12, 2026
Rajeev M. ShahDirector, 10% owner––Jun 12, 2026
Peter KolchinskyDirector, 10% owner9,317,24615.24%Jun 12, 2026
Natasha HerndayDirector15,4810.03%Jun 12, 2026
Ra Capital Management, L.P.Director, 10% owner2,5000.00%Jun 12, 2026
Alana B. McNultyDirector6,2500.01%Jun 13, 2025
Sheila GujrathiDirector118,8890.19%Jun 13, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
David Alan Campbell
President and CEO, Director
Jul 31, 2026Gift−123,840––264,742
David Alan Campbell
President and CEO, Director
Jul 8, 2026Option exercise+7,000$4.21$29.47K388,582
Jake Simson
Director
Jun 11, 2026Award+5,500––11,750
Winston Kung
Director
Jun 11, 2026Award+5,500––11,750
RA Capital Nexus Fund II, L.P.
Director
Jun 11, 2026Award+5,500––11,750
Vickie L. Capps
Director
Jun 11, 2026Award+5,500––79,598
Eric Dobmeier
Director
Jun 11, 2026Award+5,500––15,481
Natasha Hernday
Director
Jun 11, 2026Award+5,500––15,481
Ronald W. Barrett
Director
Jun 11, 2026Award+5,500––11,750
Janeen Noel Doyle
Chief Corp. & Bus. Dev. Ofcr
Jun 2, 2026Sale−4,059$14.03$56.95K75,941
Maria Dobek
Vice President, Accounting
May 11, 2026Sale−2,038$14.17$28.88K32,270
William Go
Chief Medical Officer
Feb 2, 2026Award+44,000––44,000
Maria Dobek
Vice President, Accounting
Jan 2, 2026Sale−1,462$13.73$20.07K15,373
Maria Dobek
Vice President, Accounting
Jan 2, 2026Award+18,935––34,308
Andrew Hollman Meyer
Chief Business Officer
Jan 2, 2026Sale−1,879$13.73$25.80K83,095
David Alan Campbell
President and CEO, Director
Jan 2, 2026Sale−8,072$13.73$110.83K284,982
David Alan Campbell
President and CEO, Director
Jan 2, 2026Award+96,600––381,582
Charles M. Winter
Chief Technical Officer
Jan 2, 2026Sale−2,401$13.73$32.97K77,721
Charles M. Winter
Chief Technical Officer
Jan 2, 2026Award+28,600––106,321
Zachariah McIver
Chief Medical Officer
Jan 2, 2026Sale−2,714$13.73$37.26K23,286
Zachariah McIver
Chief Medical Officer
Jan 2, 2026Award+29,000––52,286
Janeen Noel Doyle
Chief Corp. & Bus. Dev. Ofcr
Jan 2, 2026Award+36,000––80,000
Thomas DiRaimondo
Chief Scientific Officer
Jan 2, 2026Award+31,400––155,825
Thomas DiRaimondo
Chief Scientific Officer
Jan 2, 2026Sale−2,505$13.73$34.39K124,425
Andrew Hollman Meyer
Chief Business Officer
Dec 1, 2025Option exercise+3,333$10.59$35.30K88,307
Andrew Hollman Meyer
Chief Business Officer
Dec 1, 2025Sale(10b5-1 plan)−2,700$32.85$88.70K85,607
Andrew Hollman Meyer
Chief Business Officer
Dec 1, 2025Sale(10b5-1 plan)−633$33.52$21.22K84,974
Andrew Hollman Meyer
Chief Business Officer
Nov 14, 2025Option exercise+3,333$10.59$35.30K88,307
Andrew Hollman Meyer
Chief Business Officer
Nov 14, 2025Sale(10b5-1 plan)−3,333$30.00$99.99K84,974
Andrew Hollman Meyer
Chief Business Officer
Oct 28, 2025Option exercise+6,666$10.59$70.59K98,804
Andrew Hollman Meyer
Chief Business Officer
Oct 28, 2025Option exercise+9,999$4.21$42.10K92,138
Andrew Hollman Meyer
Chief Business Officer
Oct 28, 2025Sale(10b5-1 plan)−16,665$30.06$500.95K82,139
Eric Dobmeier
Director
Jun 11, 2025Award+3,750––9,981
Capital Healthcare Fund LP RA
Director, 10% owner
Jun 11, 2025Award+3,750––6,250
Winston Kung
Director
Jun 11, 2025Award+3,750––6,250
Jake Simson
Director
Jun 11, 2025Award+3,750––6,250
Sheila Gujrathi
Director
Jun 11, 2025Award+3,750––118,889
Natasha Hernday
Director
Jun 11, 2025Award+3,750––8,731
Ronald W. Barrett
Director
Jun 11, 2025Award+3,750––6,250
Alana B. McNulty
Director
Jun 11, 2025Award+3,750––6,250
Vickie L. Capps
Director
Jun 11, 2025Award+3,750––74,098
Janeen Noel Doyle
Chief Corp. & Bus. Dev. Ofcr
Jun 2, 2025Award+44,000––44,000
Andrew Hollman Meyer
Chief Business Officer
May 1, 2025Option exercise+3,333$4.21$14.03K85,472
Andrew Hollman Meyer
Chief Business Officer
May 1, 2025Sale(10b5-1 plan)−2,933$31.95$93.71K82,539
Andrew Hollman Meyer
Chief Business Officer
May 1, 2025Sale(10b5-1 plan)−400$32.60$13.04K82,139
Andrew Hollman Meyer
Chief Business Officer
Apr 21, 2025Option exercise+3,334$4.21$14.04K85,473
Andrew Hollman Meyer
Chief Business Officer
Apr 21, 2025Sale(10b5-1 plan)−3,334$30.00$100.02K82,139
Capital Healthcare Fund LP RA
Director, 10% owner
Mar 7, 2025Buy+110,206$31.02$3.42M10,141,287
Capital Healthcare Fund LP RA
Director, 10% owner
Mar 6, 2025Buy+372,093$30.78$11.45M10,031,081
Capital Healthcare Fund LP RA
Director, 10% owner
Mar 5, 2025Buy+37,455$31.30$1.17M9,658,988
Capital Healthcare Fund LP RA
Director, 10% owner
Mar 5, 2025Buy+304,287$30.56$9.30M9,621,533
Andrew Hollman Meyer
Chief Business Officer
Mar 3, 2025Sale(10b5-1 plan)−2,433$31.88$77.56K83,040
Andrew Hollman Meyer
Chief Business Officer
Mar 3, 2025Sale(10b5-1 plan)−901$32.85$29.60K82,139
Andrew Hollman Meyer
Chief Business Officer
Mar 3, 2025Option exercise+3,334$4.21$14.04K85,473
Andrew Hollman Meyer
Chief Business Officer
Feb 3, 2025Option exercise+3,334$4.21$14.04K85,473
Andrew Hollman Meyer
Chief Business Officer
Feb 3, 2025Sale(10b5-1 plan)−2,418$42.08$101.75K83,055
Andrew Hollman Meyer
Chief Business Officer
Feb 3, 2025Sale(10b5-1 plan)−816$42.77$34.90K82,239
Andrew Hollman Meyer
Chief Business Officer
Feb 3, 2025Sale(10b5-1 plan)−100$43.60$4.36K82,139
David Alan Campbell
President and CEO, Director
Jan 7, 2025Sale(10b5-1 plan)−5,000$60.00$300.00K293,054
Andrew Hollman Meyer
Chief Business Officer
Jan 2, 2025Sale(10b5-1 plan)−200$57.37$11.47K82,139

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
11.08%
5M shares short
Days to cover
8.0
At 1M shares a day
Change since last report
+0.1%
From 5M shares
Short volume, 20 days
37.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Janux Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 18,477 shares on Sep 1, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Janeen Noel Doyle
Officer
Jun 2, 20264,059$56.94KJun 2, 2026Restricted Stock Units vesting under registered plan
Andy Meyer
Former Affiliate
Apr 13, 20261,877$28.25KApr 13, 2026Exercise of options under a registered plan
Zachariah McIver
Former Officer
Apr 2, 202674,802$1.10MApr 2, 2026Exercise of options under a registered plan
Andy Meyer
Former Affiliate
Jan 26, 2026178,767$2.60MJan 26, 2026Exercise of options under a registered plan
Andy Meyer
Former Affiliate
Jan 23, 2026118,122$1.74MJan 23, 2026Exercise of options under a registered plan
Byron Robinson
Officer
Dec 15, 202516,666$258.37KDec 15, 2025Stock Option Exercise
Byron Robinson
Officer
Dec 8, 202550,000$826.00KDec 8, 2025Stock Option Exercise
Byron Robinson
Officer
Dec 2, 202563,125$1.03MDec 2, 2025Stock Option Exercise
Andrew Hollman Meyer
Officer
Dec 1, 20253,333$113.62KDec 1, 2025Exercise of Stock Options
Andrew Hollman Meyer
Officer
Nov 14, 20253,333$91.52KNov 14, 2025Exercise of Stock Options
Andrew Hollman Meyer
Officer
Oct 28, 202516,665$455.79KOct 28, 2025Exercise of Stock Options
Andrew Hollman Meyer
Officer
May 1, 20253,333$110.66KMay 1, 2025Exercise of Stock Options
Andrew Hollman Meyer
Officer
Apr 21, 20253,334$98.99KApr 21, 2025Exercise of Stock Options
Andrew Hollman Meyer
Officer
Mar 3, 20253,334$109.66KMar 3, 2025Exercise of Stock Options
Andrew Hollman Meyer
Officer
Feb 3, 20253,334$144.96KFeb 3, 2025Exercise of Stock Options

See a number that looks wrong?